Integrated Wealth Management (Palm Desert)’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-74
Closed -$2K 760
2016
Q3
$2K Hold
74
﹤0.01% 1076
2016
Q2
$2K Hold
74
﹤0.01% 1088
2016
Q1
$2K Sell
74
-104
-58% -$2.79K ﹤0.01% 1018
2015
Q4
$5K Buy
178
+104
+141% +$2.88K ﹤0.01% 939
2015
Q3
$2K Sell
74
-1,914
-96% -$54.2K ﹤0.01% 1118
2015
Q2
$54K Sell
1,988
-218
-10% -$6.13K 0.02% 385
2015
Q1
$58K Buy
+2,206
New +$50.8K 0.02% 364

Other funds holding NVO

Integrated Wealth Management (Palm Desert)'s NVO Position: Q4 2016 in Review

Integrated Wealth Management (Palm Desert) sold out of Novo Nordisk (NVO) in Q4 2016, closing a stake of 74 shares — an estimated $2K sold.

Integrated Wealth Management (Palm Desert) first reported a position in NVO in Q1 2015 and held it in 7 quarters. The position peaked at $58K in Q1 2015. 483 funds tracked by Wall St. Rank hold NVO as of Q4 2016.

  • Integrated Wealth Management (Palm Desert) reported no remaining Novo Nordisk position as of Q4 2016 after selling out during the quarter.
  • Integrated Wealth Management (Palm Desert) sold 74 Novo Nordisk shares in Q4 2016, an estimated $2K.
  • Integrated Wealth Management (Palm Desert) first reported a position in Novo Nordisk in Q1 2015 and held it in 7 quarters.
  • Integrated Wealth Management (Palm Desert)'s Novo Nordisk position peaked at $58K in Q1 2015.
  • 483 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2016.

Based on Integrated Wealth Management (Palm Desert)'s 13F filing for Q4 2016, filed 6 Jan 2017.